Literature DB >> 25652905

Expression and role of V1A subunit of V-ATPases in gastric cancer cells.

Pengfei Liu1, Haijiao Chen, Lanxiu Han, Xiaoping Zou, Weidong Shen.   

Abstract

BACKGROUND: Vacuolar-ATPases (V-ATPases) play an important role in maintaining a relatively neutral pHi (internal pH) and are responsible for the progression of cancer. V-ATPases contain different subunits and few studies have been conducted on subunit V1A. This study aimed to investigate the gene expression of V1A subunit of V-ATPases in gastric cancer tissues and explore its role in the progression and prognosis of gastric cancer.
METHODS: The protein expressions of the V1A subunit of V-ATPase gene in 100 normal gastric specimens and 100 gastric cancer tissues were determined by immunohistochemistry. The role of V1A subunit of V-ATPases was studied using a specific small interfering RNA (siRNA).
RESULTS: The positive expression rate of the V1A subunit of V-ATPases was 76 % in gastric cancer tissue samples, much higher than that in normal tissue samples (30 %, P < 0.05), and was correlated with histological grade (P = 0.001), lymph node metastasis (P = 0.002), TNM (P = 0.040), and vascular invasion (P = 0.010), but not with patient age, sex, depth of tumor invasion, tumor size, or histological type. The median overall survival times of 76 patients who had positive staining for tumor cell V1A subunit of V-ATPases and 24 patients who had negative staining were 31.7 and 59.2 months, respectively. When the expression of V1A subunit was knocked down using siRNA, the proliferation and invasion of gastric cancer cells in vitro were significantly inhibited.
CONCLUSIONS: V1A subunit of V-ATPases can be a prognostic indicator for poor outcome and is a therapeutic target in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652905     DOI: 10.1007/s10147-015-0782-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  24 in total

Review 1.  Plasmalemmal vacuolar-type H+-ATPase in cancer biology.

Authors:  Souad R Sennoune; Defeng Luo; Raul Martínez-Zaguilán
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

Review 2.  An update in the structure, function, and regulation of V-ATPases: the role of the C subunit.

Authors:  M Pérez-Sayáns; J M Suárez-Peñaranda; F Barros-Angueira; P G Diz; J M Gándara-Rey; A García-García
Journal:  Braz J Biol       Date:  2012-02       Impact factor: 1.651

3.  Inhibition of vacuolar-type (H+)-ATPase by the cytostatic macrolide apicularen A and its role in apicularen A-induced apoptosis in RAW 264.7 cells.

Authors:  JangJa Hong; Aya Yokomakura; Yasuhiro Nakano; Kenji Ishihara; Makoto Kaneda; Mitsue Onodera; Ken-ichi Nakahama; Ikuo Morita; Kazuaki Niikura; Jong-Woong Ahn; OkPyo Zee; Kazuo Ohuchi
Journal:  FEBS Lett       Date:  2006-04-21       Impact factor: 4.124

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa.

Authors:  A García-García; M Pérez-Sayáns; M J Rodríguez; J Antúnez-López; F Barros-Angueira; M Somoza-Martín; J M Gándara-Rey; J M Aguirre-Urízar
Journal:  Biotech Histochem       Date:  2011-04-28       Impact factor: 1.718

6.  The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.

Authors:  Xiaodong Lu; Wenxin Qin; Jinjun Li; Ning Tan; Dongning Pan; Haitao Zhang; Li Xie; Genfu Yao; Huiqun Shu; Ming Yao; Dafang Wan; Jianren Gu; Shengli Yang
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

Review 7.  V-ATPase functions in normal and disease processes.

Authors:  Ayana Hinton; Sarah Bond; Michael Forgac
Journal:  Pflugers Arch       Date:  2007-11-20       Impact factor: 3.657

Review 8.  V-ATPase inhibitors and implication in cancer treatment.

Authors:  Mario Pérez-Sayáns; José Manuel Somoza-Martín; Francisco Barros-Angueira; José Manuel Gándara Rey; Abel García-García
Journal:  Cancer Treat Rev       Date:  2009-09-15       Impact factor: 12.111

Review 9.  Tumor acidity, chemoresistance and proton pump inhibitors.

Authors:  Angelo De Milito; Stefano Fais
Journal:  Future Oncol       Date:  2005-12       Impact factor: 3.404

10.  Archazolid and apicularen: novel specific V-ATPase inhibitors.

Authors:  Markus Huss; Florenz Sasse; Brigitte Kunze; Rolf Jansen; Heinrich Steinmetz; Gudrun Ingenhorst; Axel Zeeck; Helmut Wieczorek
Journal:  BMC Biochem       Date:  2005-08-04       Impact factor: 4.059

View more
  16 in total

1.  Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.

Authors:  Christina M McGuire; Michael P Collins; GeHong Sun-Wada; Yoh Wada; Michael Forgac
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 2.  Recent Insights into the Structure, Regulation, and Function of the V-ATPases.

Authors:  Kristina Cotter; Laura Stransky; Christina McGuire; Michael Forgac
Journal:  Trends Biochem Sci       Date:  2015-10       Impact factor: 13.807

Review 3.  The Function of V-ATPases in Cancer.

Authors:  Laura Stransky; Kristina Cotter; Michael Forgac
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

4.  The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer.

Authors:  Kristina Cotter; Rachel Liberman; GeHong Sun-Wada; Yoh Wada; Dennis Sgroi; Stephen Naber; Dennis Brown; Sylvie Breton; Michael Forgac
Journal:  Oncotarget       Date:  2016-07-19

5.  Expression and Transcriptional Regulation of Human ATP6V1A Gene in Gastric Cancers.

Authors:  Pin Wang; Lei Wang; Jie Sha; Guochun Lou; Nannan Lu; Bo Hang; Jian-Hua Mao; Xiaoping Zou
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

6.  Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.

Authors:  Sung Wook Son; Seok-Hyung Kim; Eun-Yi Moon; Dong-Hoon Kim; Suhkneung Pyo; Sung Hee Um
Journal:  Oncotarget       Date:  2016-08-02

7.  Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells.

Authors:  Haijiao Chen; Pengfei Liu; Ting Zhang; Yi Gao; Yingdi Zhang; Xiuyun Shen; Xiao Li; Weidong Shen
Journal:  Oncol Rep       Date:  2018-01-04       Impact factor: 3.906

Review 8.  Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition.

Authors:  Jan Hraběta; Marie Belhajová; Hana Šubrtová; Miguel Angel Merlos Rodrigo; Zbyněk Heger; Tomáš Eckschlager
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 9.  Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer.

Authors:  Bradleigh Whitton; Haruko Okamoto; Graham Packham; Simon J Crabb
Journal:  Cancer Med       Date:  2018-06-21       Impact factor: 4.452

Review 10.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.